Compare GTE & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTE | ARCT |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.3M | 189.9M |
| IPO Year | 2007 | 2019 |
| Metric | GTE | ARCT |
|---|---|---|
| Price | $8.06 | $8.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $27.70 |
| AVG Volume (30 Days) | ★ 680.0K | 471.2K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $374,460,000.00 | $82,031,000.00 |
| Revenue This Year | $1.39 | N/A |
| Revenue Next Year | $2.84 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 41.99 | N/A |
| 52 Week Low | $3.09 | $5.85 |
| 52 Week High | $9.74 | $24.14 |
| Indicator | GTE | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 67.97 |
| Support Level | $3.75 | $6.08 |
| Resistance Level | $9.74 | $8.87 |
| Average True Range (ATR) | 0.49 | 0.46 |
| MACD | -0.15 | 0.12 |
| Stochastic Oscillator | 30.21 | 89.20 |
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.